Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22389093

Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report

Author
NIERENBERG, A. A1 ; HUSAIN, M. M2 ; TRIVEDI, M. H2 ; FAVA, M1 ; WARDEN, D2 ; WISNIEWSKI, S. R3 ; MIYAHARA, S3 ; RUSH, A. J4
[1] Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA, United States
[2] The University of Texas Southwestern Medical Center, Department of Psychiatry, Dallas, TX, United States
[3] Epidemiology Data Center, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States
[4] The University of Texas Southwestern Medical Center, Departments of Clinical Sciences and Psychiatry, Dallas, TX, United States
Source

Psychological medicine (Print). 2010, Vol 40, Num 1, pp 41-50, 10 p ; ref : 1 p.1/4

CODEN
PSMDCO
ISSN
0033-2917
Scientific domain
Cognition; Psychology, psychopathology, psychiatry
Publisher
Cambridge University Press, Cambridge
Publication country
United Kingdom
Document type
Article
Language
English
Author keyword
Major depression remission residual symptoms
Keyword (fr)
Antidépresseur Citalopram Environnement social Etat dépressif Etude longitudinale Facteur risque Homme Pharmacothérapie Psychotrope Récidive Rémission Santé mentale Santé publique Symptomatologie Etats-Unis Inhibiteur recapture Inhibiteur sélectif recapture sérotonine Neurotransmetteur Sérotonine Traitement Trouble de l'humeur Amérique du Nord Amérique
Keyword (en)
Antidepressant agent Citalopram Social environment Depression Follow up study Risk factor Human Pharmacotherapy Psychotropic Relapse Remission Mental health Public health Symptomatology United States Reuptake inhibitor Selective serotonin reuptake inhibitor Neurotransmitter Serotonin Treatment Mood disorder North America America
Keyword (es)
Antidepresor Citalopram Contexto social Estado depresivo Estudio longitudinal Factor riesgo Hombre Farmacoterapia Psicotropo Recaida Remisión Salud mental Salud pública Sintomatología Estados Unidos Inhibidor recaptura Inhibidor selectivo recaptura serotonin Neurotransmisor Serotonina Tratamiento Trastorno humor America del norte America
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B02 Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B18 Psychopathology. Psychiatry / 002B18C Adult and adolescent clinical studies / 002B18C07 Mood disorders / 002B18C07A Depression

Francis
770 Psychology. Psychoanalysis. Psychiatry / 770-D Psychopathology. Psychiatry / 770-D03 Adult and adolescent clinical studies / 770-D03G Mood disorders / 770-D03G01 Depression

Francis
770 Psychology. Psychoanalysis. Psychiatry / 770-E Psychopharmacology / 770-E02 Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer…

Discipline
Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
Origin
Inist-CNRS
Database
FRANCIS ; PASCAL
INIST identifier
22389093

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web